Duke University’s MURDOCK Study would continue as planned if lead investigator Dr. Rob Califf is tapped to head the U.S. Food and Drug Administration.

"We would carry on without a moment’s hesitation," said Victoria Christian, chief operating officer for the long-term medical study based at the N.C. Research Campus.

The ambitious study already has plans to expand. Researchers will add cancer and disorders of the central nervous system to their list of targeted diseases, which include hepatitis C, heart disease, obesity and arthritis, Christian said.

Online blogs that cover the pharmaceutical industry have been buzzing since the Nov. 4 election with predictions about who will lead the FDA. Califf is a major contender.

For details, see the Salisbury Post report.